VeriMombutylene glycol dicaprylate/dicaprate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
Pregnancy-safe products containing butylene glycol dicaprylate/dicaprate
Related ingredients
Frequently asked questions
- butylene glycol dicaprylate/dicaprate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
- butylene glycol dicaprylate/dicaprate est-il sûr pendant l'allaitement ?
- No evidence of lactation/transfer concerns or reproductive toxicity in available regulatory/peer review sources. Given low dermal absorption from topical esters, maternal systemic exposure from cosmetic use is expected to be low; no data for milk transfer were found.
- butylene glycol dicaprylate/dicaprate est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental hazards identified. Because infant skin has higher surface‑area‑to‑weight and an immature barrier, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Ingredient is used as an emollient/skin conditioning agent (CosIng/PubChem) with no infant‑specific restrictions identified.
- Comment VeriMom évalue-t-il butylene glycol dicaprylate/dicaprate ?
- VeriMom évalue butylene glycol dicaprylate/dicaprate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à butylene glycol dicaprylate/dicaprate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à butylene glycol dicaprylate/dicaprate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.